3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
28
Active not recruiting
12
Completed
11
Terminated
3
Withdrawn
1
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
28
Neoplasms
26
Prostatic Neoplasms
22
Colorectal Neoplasms
18
Head and Neck Neoplasms
14
Pancreatic Neoplasms
12
Melanoma
10
Lung Neoplasms
10
Brain Neoplasms
10
Neoplasm Metastasis
9
Carcinoma, Renal Cell
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Non-Small-Cell Lung
8
Triple Negative Breast Neoplasms
7
Recurrence
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Multiple Myeloma
7
Lymphoma, Follicular
7
Lymphoma
7
Glioblastoma
7
Leukemia, Myeloid, Acute
6
Leukemia
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Ovarian Neoplasms
5
Lymphoma, B-Cell
5
Kidney Neoplasms
5
Hematologic Neoplasms
5
Sarcoma
4
Liver Neoplasms
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasms, Germ Cell and Embryonal
×
1 year
×
Clear all
NCT06940804
2025-07-02
AVENTURINE
BioNTech SE
Phase 2
Withdrawn